Atlas Trials

Idiopathic Pulmonary Fibrosis

438 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Idiopathic Pulmonary Fibrosis

RecordFirmDate
Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis (NCT00071461)Actelion2003-08-01
Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study (NCT00131274)Daniels, Craig E., M.D.2003-04-01
Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis (NCT00189176)University of Michigan2003-03-01
A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT00047658)InterMune2001-11-01
Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis (NCT00262405)University of Michigan2001-01-01
A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT00047645)InterMune2000-04-01
A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT03591926)Biosplice Therapeutics, Inc.1900-01-01
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP) (NCT02171156)Boehringer Ingelheim
Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone (NCT02141087)Genentech, Inc.
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (NCT02230982)Boehringer Ingelheim
← Previous Next →

Track Idiopathic Pulmonary Fibrosis automatically

Every clearance here is in the API, with alerts when new ones post.